3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow IgPro20: new trials by email Literature Review of IgPro20 trials Research Report on IgPro20
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) IgPro20 - Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Phase 3 | Completed | CSL Behring | 82 | 2014-07-30 | 2018-10-02 |
| Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study) IgPro20 - Primary Immunodeficiency (PID) | Phase 3 | Completed | CSL Behring | 40 | 2008-08-01 | 2014-04-02 |
| Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID) IgPro20 - Primary Immune Deficiency | Phase 3 | Completed | CSL Behring | 21 | 2008-06-01 | 2014-04-02 |
Primary Immunodeficiency Diseases (2) · Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)
CSL Behring (3)
France (2) · Germany (2) · Spain (2) · United Kingdom (2) · United States (2) · Australia (1) · Canada (1) · Czechia (1) · Italy (1) · Japan (1) · Netherlands (1) · Poland (1) · Romania (1) · Sweden (1) · Switzerland (1)
2008 (1)